Intrinsic Value of S&P & Nasdaq Contact Us

Integer Holdings Corporation ITGR NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
68/100
3/7 Pass
SharesGrow Intrinsic Value
$127.30
+43.6%
Analyst Price Target
$102.75
+15.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Integer Holdings Corporation (ITGR) trades at a trailing P/E of 29.5, forward P/E of 13.7. Trailing earnings yield is 3.39%, forward earnings yield 7.33%. PEG 0.11 (Peter Lynch undervalued ≤1.0). Graham Number is $57.65.

Criteria proven by this page:

  • VALUE (53/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 13.7 (down from trailing 29.5) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.11 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 3.39% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 7.33% as earnings recover.
  • Analyst consensus target $102.75 (+15.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 68/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
68/100
SG Score
View full scorecard →
~
VALUE
53/100
Price-to-Earnings & upside
Proven by this page
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
→ Income
GROWTH
80/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — ITGR

Valuation Multiples
P/E (TTM)29.5
Forward P/E13.7
PEG Ratio0.11
Forward PEG0.11
P/B Ratio1.74
P/S Ratio1.65
EV/EBITDA12.2
Per Share Data
EPS (TTM)$2.95
Forward EPS (Est.)$6.49
Book Value / Share$50.10
Revenue / Share$53.17
FCF / Share$4.28
Yields & Fair Value
Earnings Yield3.39%
Forward Earnings Yield7.33%
Dividend Yield0.00%
Graham Number$57.65
SharesGrow IV$127.30 (+43.6%)
Analyst Target$102.75 (+15.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 152.1 -0.92 1.25 0.84 -
2017 21.3 0.02 1.59 1.25 -
2018 14.6 0.10 2.31 2.02 -
2019 27.2 -0.59 2.28 2.09 -
2020 34.5 -2.15 2.10 2.48 -
2021 29.2 1.46 2.08 2.31 -
2022 34.2 -1.13 1.60 1.70 -
2023 36.4 0.96 2.17 2.12 -
2024 37.1 1.15 2.75 2.59 -
2025 26.5 -1.49 1.56 1.47 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2017 $2.08 $1.14B $66.68M 5.9%
2018 $5.15 $1.22B $167.96M 13.8%
2018 $5.15 $1.22B $167.96M 13.8%
2019 $2.77 $1.26B $96.34M 7.7%
2020 $2.33 $1.07B $77.26M 7.2%
2021 $2.80 $1.22B $96.81M 7.9%
2022 $1.96 $1.38B $66.38M 4.8%
2023 $2.69 $1.6B $90.65M 5.7%
2024 $3.36 $1.72B $119.9M 7%
2025 $2.89 $1.85B $102.81M 5.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $6.49 $6.42 – $6.55 $1.85B $1.84B – $1.86B 6
2027 $7.23 $7.02 – $7.36 $1.97B $1.92B – $1.99B 6
2028 $7.88 $7.76 – $7.95 $2.08B $2.08B – $2.08B 3
2029 $8.64 $8.50 – $8.71 $2.25B $2.22B – $2.26B 4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message